WHO ICTRP trial
Noscatem and COVID-19
IRCT20180103038199N11 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20180103038199N11 |
|---|---|
| Public title | Noscatem and COVID-19 |
| Scientific title | Evaluation of the effectiveness of Noscatem herbal syrup on the clinical symptoms of outpatients with COVID-19 |
| Primary sponsor | Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | COVID-19 disease. COVID-19;U07.1 |
| Interventions | Intervention 1: Intervention group: receiving common treatments, including adult cold two tablets every eight hours, one tablespoon of diphenhydramine syrup every 8 hours, vitamin C 1000 mg effervescent + Noscatem syrup (10 mg/5ml) prepared… |
| Registration date | Feb 9, 2022 |
| Target size | 70 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: